Although basic research studies targeting these proteins have had satisfactory results in the hope of resulting in a new treatment in the fight against cancer, the development of new therapies based on the activation or inhibition of oncogenic protein kinases is facing numerous difficulties. Here, WEE1 is linked to cancer.